Martin, Gilles, Zhiguo Nie, and George R. Siggins. Metabotropic studies, it is now widely accepted that mGluRs can be diglutamate receptors regulate N-methyl-D-aspartate-mediated syn-vided into three groups. The first group (group 1) consists aptic transmission in nucleus accumbens. J. Neurophysiol. 78: of the mGluR1 and mGluR5 subtypes, that increase phospha- [3028][3029][3030][3031][3032][3033][3034][3035][3036][3037][3038] 1997. We recorded intracellularly from core nucleus tidylinoside (PI) turnover, whereas groups 2 and 3, comprisaccumbens (NAcc) neurons in brain slices to study the regulation ing the mGluR2 and 3 and mGluR4, 6, 7, and 8 subtypes, by metabotropic glutamate receptors (mGluRs) of pharmacologi-respectively, decrease forskolin-stimulated cyclic AMP for- effect of trans-ACPD on NMDA-excitatory postsynaptic potentials (NMDA-EPSPs) in hippocampus (Aniksztejn et al. 1992; Fitzjohn et al. 1996) In the present study we have focused on the effects of pic glutamate receptors (mGluRs) (Sladeczek et al. 1985 ; various mGluR agonists and antagonists on NMDA-EPSCs Sugiyama and Watanabe 1989), pharmacological, anatomic, in core nucleus accumbens (NAcc), a structure considered electrophysiological, and molecular studies have revealed to constitute the ventral aspect of the striatum. In the course the complexity of this new category of receptors. Unlike the of our studies on opiate and alcohol effects in the NAcc, we ionotropic glutamate receptors composed of several subunits noted pronounced interactions of these drugs of abuse with forming a multimeric ligand-gated channel, mGluRs consist NMDA receptor-mediated functions (Martin et al. 1997 ; of a single seven-transmembrane spanning protein. Further-Nie et al. 1994). Indeed, many studies support a role for more, mGluRs are coupled via G-proteins to cascades of both NMDA receptors and for the NAcc in drug dependence intracellular messengers responsible for many of their physi- (Koob et al. 1992; Self and Nestler 1995). Thus MK801, a specific noncompetitive antagonist of NMDA receptors, ological effects. Based on biochemical and pharmacological 3028 0022-3077/98 $5.00
effect of trans-ACPD on NMDA-excitatory postsynaptic potentials (NMDA-EPSPs) in hippocampus (Aniksztejn et al. 1992; Fitzjohn et al. 1996) and in neocortex (Rahman In the present study we have focused on the effects of pic glutamate receptors (mGluRs) (Sladeczek et al. 1985 ; various mGluR agonists and antagonists on NMDA-EPSCs Sugiyama and Watanabe 1989), pharmacological, anatomic, in core nucleus accumbens (NAcc), a structure considered electrophysiological, and molecular studies have revealed to constitute the ventral aspect of the striatum. In the course the complexity of this new category of receptors. Unlike the of our studies on opiate and alcohol effects in the NAcc, we ionotropic glutamate receptors composed of several subunits noted pronounced interactions of these drugs of abuse with forming a multimeric ligand-gated channel, mGluRs consist NMDA receptor-mediated functions (Martin et al. 1997 ; of a single seven-transmembrane spanning protein. Further-Nie et al. 1994) . Indeed, many studies support a role for more, mGluRs are coupled via G-proteins to cascades of both NMDA receptors and for the NAcc in drug dependence intracellular messengers responsible for many of their physi- (Koob et al. 1992; Self and Nestler 1995) . Thus MK801, a specific noncompetitive antagonist of NMDA receptors, ological effects. Based on biochemical and pharmacological to resting membrane potential (RMP) with increments of /10 mV attenuates some aspects of opiate dependence and tolerance for the five subsequent steps. In a smaller group of neurons, we (Elliott et al. 1994; Tiseo et al. 1994; used current clamp with step durations of 210 ms. and Akil 1989 . Furthermore, Fundytus and Coderre (1994) recently showed that chronic intracerebroventricular Synaptic stimulation treatment with the mGluR antagonist (/)-a-methyl-4-carboxyphenylglycine (MCPG), but not a-amino-3-hydroxyWe studied the NMDA component of monosynaptic EPSCs in 5-methyl-4-isoxazolepropionic acid (AMPA) and kainate voltage-clamp mode, using an I-V protocol (400-ms step duration) receptor antagonists, reduced opiate withdrawal symptoms, to measure EPSC areas evoked at different membrane potentials suggesting that mGluRs also might be partially responsible (see Martin et al. 1997) . The NMDA-EPSCs were elicited by local for these phenomena. Furthermore, immunocytochemical (''focal'' or ''proximal'') stimulation (see below) triggered 100 ms after the onset of, and therefore superimposed on, the voltage (Romano et al. 1995) and in situ hybridization (Tanabe et pulse. We averaged two traces for the same voltage step size with al. Testa et al. 1995 ) studies have shown high levels superimposed NMDA-EPSCs. To minimize the influence of stimuof mGluR5 and mGluR3 protein and mRNA in the striatum lation artifact on the NMDA current, we injected a 2-ms duration and NAcc.
pulse into the amplifier's blanking circuitry 1 ms before the stimuTo explore further the properties and interactions of gluta-lation. mate receptors in NAcc, we have now examined the effect Synaptic responses were evoked using a tungsten bipolar stimuof mGluR agonists and antagonists on pharmacologically lating electrode with a tip separation of 1 mm. In contrast to the isolated NMDA receptor-mediated glutamatergic synaptic peri-tubercle stimulation used previously in our laboratory (Nie et transmission. The results suggest that NAcc neurons express al. 1994), we placed the stimulating electrode within the NAcc at least the group 2 and 3 mGluR subtypes. When activated, close to (within 1 mm of) the recording electrode. Stimulation parameters (7-14 V, 50 ms pulse duration, delivered at 0.1 Hz) both subtypes decrease NMDA-EPSC areas: trans-ACPD were chosen to generate a sizable and reproducible monosynaptic activates receptors that appear to be presynaptic, whereas NMDA-EPSC without spiking, and the stimulus intensity was then receptors affected by L-AP4 are located postsynaptically. A maintained constant throughout the recording period. We quantipreliminary account of these data has been published in abfied the NMDA response by measuring the area (or time integral) stract form .
under the EPSC using Axograph Software (Axon Instruments), with the analysis epoch set for the interval from 1 ms before the M E T H O D S stimulating artifact to 300 ms after (the blanking circuit held the current at baseline until 1 ms poststimulus).
Animals and slice preparation
We used male Sprague-Dawley rats (100-170 g) to prepare Drug administration NAcc slices from fresh brain tissue, as described previously (MarTo pharmacologically isolate the monosynaptic NMDA-EPSC tin et al. 1997; Yuan et al. 1992) . We rapidly removed the brain component, we superfused the slices with antagonists specific for and transferred it to cold (4ЊC), oxygenated artificial cerebrospinal non-NMDA (kainate/AMPA) receptors [10 mM 6-cyano-7-nitrofluid (ACSF) of the following composition (in mM): 130 NaCl, quinoxaline-2,3-dione (CNQX)] and GABA A receptors (15 mM 3.5 KCl, 1.25 NaH 2 PO 4 , 1.5 MgSO 4 r7H 2 O, 2 CaCl 2 , 24 NaHCO 3 , bicuculline), for at least 30 min before recording. We superfused and 10 glucose. We glued a tissue block containing NAcc to a the NMDA receptor antagonist D-2-amino-5-phosphonovaleric Teflon chuck and cut it transversely with a Vibroslice cutter (Campacid (D-APV; 60 mM) at the end of some experiments to further den Instrument) and immediately incubated the slices (400 mM verify the involvement of NMDA receptors in the EPSPs. In other thick) in the recording chamber. During initial incubation in an studies, to test for postsynaptic metabotropic agonist (trans-ACPD ''interface'' configuration, the tops of the slices were exposed to and L-AP4 ) effects, we applied NMDA locally by pressure (5-15 carbogen (95% O 2 -5% CO 2 ). After 30 min we submerged and psi, 200 mM NMDA, 2-3 s pulse duration) from a broken-tipped superfused the slices with warm (34ЊC) carbogenated ACSF, at a pipette (tip diameter Ç2 mm). In these cases, we superfused 1 mM constant rate of 3-4 ml/min. tetrodotoxin (TTX), in addition to the 10 mM CNQX and 15 mM bicuculline, to minimize presynaptic effects.
Recording
Our standard drug-testing protocol was as follows: after recording a stable membrane potential and obtaining reproducible We pulled sharp glass microelectrodes from borosilicate capillary glass (1.2 mm OD, 0.8 mm ID) on a Brown-Flaming puller NMDA receptor-evoked events for at least 15 min, we superfused the slices for 10-15 min with the ACSF-antagonist solution de-(Sutter Intruments) and filled them with 3 M KCl. Tip resistances were 60-100 MV. We used an Axoclamp 2B amplifier (Axon scribed above but also containing the mGluR receptor agonists (1-100 mM; 5-12 min) trans-ACPD, (RS)-3,5-dihydroxyphenylInstruments) to record neurons in current-clamp or discontinuous, single-electrode voltage-clamp modes. Throughout all voltage-glycine (DHPG), (2S,3S,4S)-a-(carboxycyclopropyl)-glycine (L-CCG-I), or L (/)-2-amino-4-phosphonobutyric acid (L-AP4). clamp experiments we continuously monitored electrode settling time and capacitance neutralization on a separate oscilloscope. Cur-After wash out with control ACSF solution, in some cases we superfused either another mGluR agonist (e.g., quisqualate) or an rent and voltage levels were monitored and stored on polygraph paper, digitized by a TL-1 interface (Axon Instruments) and stored mGluR agonist plus an antagonist [L(/)-2-amino-3-phosphonopropionic acid (L-AP3), (S)-2-amino-2-methyl-4-phosphonobutaon a 486 personal computer using Clampex 6.0 software (Axon Instruments). The digitized records were then analyzed with noic acid (MAP4), MCPG]. The superfusion system allowed switching of drug-ACSF solutions without disrupting the constant Clampfit and Axograph software (Axon Instruments). We recorded neurons within the core NAcc just ventral to the anterior rapid flow of the ACSF through the recording chamber (Moore et al. 1988 ). commissure. For most of the cells we constructed current-voltage (I-V ) curves in voltage-clamp mode with a 400-ms step duration;
We purchased trans-ACPD and CNQX from RBI (Natick, MA); MCPG, L-AP4, L-AP3, L-CCG-I, MAP4, DHPG, and quisqualate we measured the current just before the step and at steady state 380 ms after step onset. The first voltage step was 020 mV negative were all obtained from Tocris Cookson (Bristol, UK), and D-APV 
from Sigma (Saint Louis, MO). Table 1 shows the drugs studied and their reported mGluR sites and mode of action.
Statistics
We expressed all pooled values as means { SE. We tested for statistically significant differences between control, treatment, wash out, and mGluR-antagonist conditions by one-factor analysis of variance (ANOVA) for repeated measures, with post hoc analysis by Newman-Keuls or Fisher comparison tests. We considered P values of õ0.05 statistically significant.
R E S U L T S

Effect of Trans-ACPD on NAcc membrane properties
We examined the effects of 50 mM trans-ACPD on membrane currents in a sample of 12 cells. The mean RMP and input resistance of this sample was 085 { 0.5 ( SE ) mV and 69 { 6.3 MV, respectively. Even at 50 -100 mM, trans-ACPD did not elicit any significant inward or outward current ( Fig. 1C ) , suggesting that it did not affect membrane potential. In addition, trans-ACPD did not change the membrane conductance within a potential range These effects were followed by a significant recovery on wash out (P õ 0.05 for all concentrations). The apparent EC 50 for the trans-ACPD effect was Ç8 mM.
mGluR subtypes regulating NMDA-EPSCs
Pharmacological studies have established that trans-ACPD is a nonselective agonist for both group 1 and 2 metabotropic glutamate receptors (Pin and Duvoisin 1995) (see Table 1 ). To determine what mGluRs were responsible for the attenuation of the mean NMDA-EPSCs, we first tested two selective agonists for group 1 mGluRs, quisqualate (Pin and Duvoisin 1995) and DHPG (Gereau and Conn 1995b; Schoepp et al. 1994) and one selective for group 2 mGluRs, L-CCG-I. Figure 4A shows effect of 10 mM trans-ACPD and 1 mM quisqualate on the mean NMDA-EPSCs measured at six potentials in a group of five cells. Although trans-ACPD clearly caused a pronounced reduction of NMDA-EPSC area to 60 { 3.2% of control [F(3,87 
. Effect of different trans-ACPD concentrations on N-methyl-D-wash out for trans-ACPD).
This suggests that the group 1 aspartate-excitatory postsynaptic currents (NMDA-EPSCs) evoked at dif-receptors mGluR1 and mGluR5 were not involved in the ferent membrane potentials. Left panel: current recordings at 2 different trans-ACPD effect.
holding potentials selected from 6 tested. Right panel: graph of mean ({SE) Although 1 mM quisqualate is a concentration shown to NMDA-EPSC areas vs. membrane potential. All recordings were made in be effective on mGluRs in numerous brain structures (Calathe presence of 10 mM 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) and ACPD sensitize over repeated administration or that there is an L-AP3 -sensitive receptor that enhances NMDA-EPSCs in response to trans-ACPD.
At 0.5 mM, MCPG, the antagonist of the group 1 and 2 mGluR subtypes, also failed to significantly antagonize the effect of 10 mM trans-ACPD on the mean NMDA-EPSCs (Fig. 5A) . Thus 10 mM trans-ACPD alone and in the presence of MCPG (0.5 mM) significantly decreased NMDA-EPSC areas to 44 { 4.5% [F(2,46) Å 40.08; P õ 0.0001, n Å 4] and 40 { 0.5% [F(2,46) Å 67.95; P õ 0.001; n Å 4] of the control values, respectively. However, at 1 mM, MCPG did block the trans-ACPD-induced inhibition. When averaged over all tested potentials, 10 mM trans-ACPD in the presence of 1 mM MCPG only decreased the mean NMDA-EPSC area to 97% of control, an effect that was not significant [F(2,58) Å 0.41; P Å 0.66; Fig. 5B ]; 10 mM trans-ACPD superfused alone still markedly inhibited the NMDA currents in the same cell (Fig. 5C) .
We also tested the effect of a selective agonist of the   FIG . 4 . Lack of effect of quisqualate, (RS)-3,5-dihydroxyphenylglycine (DHPG), and L (/)-2-amino-3-phosphonopropionic acid (L-AP3) on pharmacologically isolated NMDA-EPSCs in the presence of 10 mM CNQX and 15 mM bicuculline. A: plot of mean ({SE; n Å 5) NMDA-EPSC time integrals vs. membrane potential; 10 mM trans-ACPD (10 min) markedly decreased NMDA-EPSC areas. After wash out of trans-ACPD (8 min), 1 mM quisqualate (7 min) failed to significantly decrease mean NMDA-EPSC time integrals. B: in another graph of mean NMDA-EPSC areas ( n Å 4), 4 mM quisqualate also did not change significantly (see text) the mean NMDA-EPSC areas at any potential. C: a similar lack of effect of 100 mM DHPG on the mean NMDA-EPSC area ( n Å 5) measured between 0100 and 060 mV. D: L-AP3 does not antagonize the trans-ACPD effect on NMDA-EPSCs: mean ({SE; n Å 5) NMDA-EPSC time-integrals vs. membrane potential. Alone, 10 mM trans-ACPD decreased NMDA-EPSC areas. After wash out (9 min), L-AP3 (10 min) did not antagonize the mean trans-ACPD effect but in fact may augment it (see text). Statistics: * P õ 0.05; **P õ 0.001. 1996), we assessed the effects of a higher concentration to avoid a false negative result. Figure 4B shows that 4 mM quisqualate also did not significantly (P Å 0.95; n Å 4) alter the mean NMDA-EPSC area at any potential. DHPG (100 mM) also failed to significantly (P Å 0.08; n Å 5) change the characteristics of this current over a similar range of (Fig. 4C) . By exclusion, these data suggest that (MCPG) on trans-ACPD-mediated inhibition of NMDA-EPSCs. A: transthe trans-ACPD effect is likely mediated through the group ACPD alone (10 mM) strongly reduced NMDA-EPSC time integrals aver-2 mGluRs. This is further corroborated by the fact that 0.4 aged over all membrane potentials and expressed as means { SE. This effect is followed by recovery on wash out. The presence of 0.5 mM MCPG mM L-AP3, an antagonist of the group 1 mGluRs, failed to did not prevent the subsequent trans-ACPD effect (n Å 4). B: in another antagonize the trans-ACPD effect when averaged over all group of 5 neurons treated with 1 mM MCPG, 10 mM trans-ACPD failed tested potentials in five cells (Fig. 4D) . In fact, the decreases to decrease the mean NMDA-EPSP area measured over all potentials of NMDA-EPSC area by trans-ACPD with L-AP3 were ({SE). C: current recordings at 3 different membrane potentials from a representative cell from the group in B; the effect of 10 mM trans-ACPD greater than with trans-ACPD alone, suggesting that there is completely blocked when superfused together with 1 mM MCPG is no long-term desensitization to trans-ACPD in the NAcc (MCPG / trans-ACPD), whereas trans-ACPD still decreases the NMDAslice preparation, in contrast to that shown in hippocampus EPSC area when subsequently superfused alone (t-ACPD 10). This inhibiand cerebellum (Catania et al. 1991; Lonart et al. 1992 Figure 9A shows that superfusion of 10 mM trans-ACPD did not change significantly the baseline holding current or the amplitude of the inward current evoked by exogenous NMDA application in this cell or in four other cells [F(2,4) Å 1.84; P Å 0.24, n Å 5]. In contrast, superfusion of the group 3 agonist L-AP4 (20 mM) in four different cells decreased significantly the mean NMDA current amplitudes, to 65% of control [F(2,6) Å 20.21; P õ 0.002; n Å 4; Fig. 9B ], without altering baseline holding currents. These data suggest a postsynaptic site of action for this group 3 agonist. Table 1 ). We also showed that Lcine (L-CCG-I; 2 mM) also reduces NMDA-EPSC areas. A: NMDA-EPSCs AP4, a group 3 mGluR selective agonist (Table 1) , not only (focal stimuli at upward arrow) recorded at 2 different membrane potentials before (Control), during (10 min), and after (Washout, 10 min) superfudecreased NMDA-EPSCs, but also reduced currents evoked sion of L-CCG-I. L-CCG-I markedly decreased NMDA-EPSC areas. This by exogenous NMDA. Like trans-ACPD, L-AP4 did not effect was followed by total reversal on wash out. Note that at the most affect RMP or membrane conductance. In addition, the abhyperpolarized potential the decay of the smaller NMDA-EPSC seems to sence of a trans-ACPD effect on the current elicited by be biphasic, a feature not evident at the depolarized potential. B: 2 mM Llocally applied NMDA indicates that the trans-ACPD-sen-CCG-I decreases mean NMDA-EPSC time integrals measured over all potentials by 44 { 1.1%. This effect is followed by recovery on wash out. Statistics: **P õ 0.001. group 2 mGluRs, L-CCG-I. Unlike quisqualate and DHPG, 2 mM L-CCG-I significantly decreased [to 53 { 3% of control values; F(2,70) Å 11.84; P õ 0.001; n Å 5] NMDA-EPSC areas averaged over all tested potentials (Fig. 6A) , with almost complete reversal on wash out. We also examined the effect of the group 3 agonist L-AP4. Like trans-ACPD and L-CCG-I, L-AP4 (20 mM) significantly decreased mean NMDA-EPSC areas (Fig. 7) to 57 { 3.9% of control [F(2,46) Å 33.57; P õ 0.001; n Å 4]. Interestingly, this L-AP4 inhibitory effect was almost completely abolished in the presence of MAP4 (0.5 mM), the selective antagonist of the group 3 mGluRs [ Fig. 8B ; F(2,58) Å 4.8; P Å 0.012; n Å 5]. Figure 8C shows that the L-AP4 -induced depression of NMDA current recorded at three different potentials is completely antagonized in the presence of 0.5 mM MAP4 on the same cell. This finding supports the idea that L-AP4 acts through the group 3 mGluRs. We evaluated the possibility that the trans-ACPD effect was also mediated partially via an unspecific action on the group 3 mGluRs, using MAP4 as an antagonist of this group of mGluRs. Figure 8A Brief downward deflections were current responses to constant voltage steps used to monitor input conductance. Trans-ACPD (10 mM) had no effect on the NMDA currents. B: by contrast, 20 mM L-AP4 decreased the NMDA current to 66% of control in another cell.
to PI hydrolysis (see for review Pin and Duvoisin 1995) . Support for this idea comes from the work by Gereau and Conn (1995b) , who showed that 100 mM DHPG induced a strong inward current via mGluR5 activation in oocytes and CA1 hippocampal neurons, whereas 1 mM L-AP4 and 1 mM (2S,1R,2R,3R)-2-(2,3-dicarboxycyclopropyl) (DCG-IV), a group 2 mGluR agonist, had no effect. They also observed FIG . 8. Effect of (S)-2-amino-2-methyl-4-phosphonobutanoic acid that DHPG, but not DCG-IV or L-AP4, reduced the slow (MAP4) on trans-ACPD-and L-AP4 -mediated inhibitions, averaged over AHP and blocked spike frequency adaptation. Similarly, all membrane potentials and expressed as mean { SE. A: trans-ACPD Guérineau et al. (1995) showed that 50 mM 1S,3R-ACPD alone (10 mM) strongly reduced NMDA-EPSC areas with recovery to near activated a cationic conductance in neurons of organotypic control after wash out. The presence of 0.5 mM MAP4 did not antagonize this effect. B: by contrast, 0.5 mM MAP4 almost completely antagonized hippocampal slice cultures, probably via mGluR1 or the inhibition elicited by L-AP4 in another group of neurons ( n Å 5). C: mGluR5 activation because quisqualate (0.5 mM) was more current recordings at 3 different membrane potentials in a representative effective than 1S,3R-ACPD.
cell from the group in B. The effect of 20 mM L-AP4 is completely blocked when superfused together with 0.5 mM MAP4 (MAP4 / L-AP4 ), whereas it still decreases the NMDA-EPSC area when subsequently superfused alone (L-AP4). This inhibition is followed by a recovery on wash out (same cell; RMP Å 085 mV Å holding potential).
sitive receptors are located on presynaptic terminals (Fig.  10) . In contrast, the inhibition of NMDA currents by suggests that group 3 mGluRs are postsynaptic.
Absence of trans-ACPD effect on basic membrane properties
One of the most surprising findings of our study is that neither quisqualate nor DHPG, selective agonists of the group 1 mGluRs (mGluR1 and mGluR5), had any apparent effect on NMDA receptor-mediated synaptic transmission or on passive membrane properties of the NAcc core neurons, at concentrations known to be effective in other slice preparations. This contrasts with anatomic studies showing In our study, the apparent absence of mGluR1 effects our study. The hypothesis that mGluR2/3 may act presynaptically is supported further by anatomic data (Ohishi et al. could be explained by recent anatomic data. For example, it has been shown that the mGluR1 subtype is expressed 1994) showing that these receptors are expressed presynaptically in the cerebellum. The controversy over what mGluR presynaptically in structures such as the olfactory bulb (Van den Pol 1995) . Importantly, other data suggest that mGluR1 subtypes control glutamate release might reflect the regionspecific existence of different presynaptic mGluRs. receptors in the NAcc are located on dopaminergic terminals (Testa et al. 1994b) . The possibility that trans-ACPD-senWe also found that L-AP4, like trans-ACPD, decreased NMDA-EPSC areas. This effect is not surprising because it sitive receptors regulate dopamine release in the NAcc has been suggested recently by studies (Arai et al. 1996 ; Ohno has been reported by several groups for various brain regions (Baskys and Malenka 1991; Burke and Hablitz 1994; Bushand Watanabe 1995) showing that trans-ACPD increased extracellular dopamine levels in NAcc and striatum. In addi-ell et al. 1995; Forsythe and Clements 1990) . Our most striking finding was that L-AP4 decreased the currents tion, the mGluR1 antagonist MCPG blocked this effect (Ohno and Watanabe 1995) .
evoked by exogenously applied NMDA, suggesting that the L-AP4 -sensitive receptors modulating glutamatergic synapThe situation with mGluR5 is more complex, because this receptor subtype is strongly expressed postsynaptically in tic transmission are located at least in part postsynaptically (see Fig. 10 ). Although this postsynaptic locus of action is NAcc Testa et al. 1994b) . Despite these anatomic data, our negative observations are supported surprising with regard to previous studies, a recent anatomic study (Risso-Bradley et al. 1996) has revealed that mGluR4s by electrophysiological data from the striatum where mGluR5 is also strongly expressed (Romano et al. 1995 ; might be expressed postsynaptically as well as presynaptically, because cell bodies and dendrites of hippocampal py- Shigemoto et al. 1993; Testa et al. 1995) : Burke and Hablitz (1994) found no effect of trans-ACPD on RMPs of rat ramidal neurons stained strongly for the mGluR4a receptor subtype. Interestingly, Hartveit et al. (1995) showed that neocortical pyramidal cells, where mGluR5 receptors are also expressed postsynaptically (Romano et al. 1995 ; Shi-another group 3 mGluR subtype (mGluR7) also was expressed postsynaptically in the retina. gemoto et al. 1993) . This apparent discrepancy between the anatomic and electrophysiological data remains to be If our hypothesis on the role of group 2 and 3 metabotropic receptors in NAcc is correct, we might predict from ACPD in hippocampus appears to be mediated by a direct action on the neurotransmitter release process itself. AlIn contrast to the lack of effect of trans-ACPD and L-AP4 on basic membrane properties, we found that these though the role of protein kinase C (PKC) in the modulation of postsynaptic NMDA currents has been demonstrated compounds markedly attenuated NMDA receptor-mediated events in NAcc. The absence of quisqualate and DHPG ef-(Chen and Huang 1991; Martin et al. 1993) , this mechanism may not account for the L-AP4 effect on NMDA-EPSC areas fects on NMDA-EPSC areas and the fact that L-CCG-I mimicked the trans-ACPD effect suggest that group 2 mGluRs because L-AP4 -sensitive receptors are linked principally to the protein kinase A (PKA) pathway and cAMP levels (see mediate this inhibitory action of trans-ACPD (Table 1 ). In addition, we showed that the current elicited by exogenous Table 1 ) (also see reviews of Hollmann and Heinemann 1994; . Interestingly, Colwell and Levine NMDA is not affected by trans-ACPD, indicating that the trans-ACPD-induced decrease of the NMDA-EPSC is due (1995) reported that forskolin increased the current elicited by locally applied NMDA in the striatum, supporting the to a presynaptic action. One of the first mGluR subtypes proposed for such a presynaptic effect was the group 3, L-idea that the inhitory effect of L-AP4 -sensitive receptors on the NMDA-EPSCs might be mediated by decreased cAMP AP4-sensitive mGluRs (Baskys and Malenka 1991; Forsythe and Clements 1990; Kemp et al. 1994 ; levels. Direct interaction with a G-protein could also account for the effect of mGluR4 and/or mGluR6 subtypes, because Trombley and Westbrook 1992). Our data suggesting that the apparent decrease of glutamate release is mediated by a 1S,R3-ACPD enhances NMDA-mediated responses in hippocampal slices through a mechanism involving neither PKC group 2 mGluR in the NAcc agree with the electrophysiological data of Lovinger and McCool (1995) from striatal neu-nor PKA (Harvey and Collingridge 1993) . Further studies will be required to test these intracellular mechanisms in the rons and more recently that of Kamiya (1996) from the hippocampus, who showed that the potent inhibition of NAcc. EPSPs by L-CCG-I and DCG-IV is mediated by presynaptimGluR subtypes responsible for the decrease of NMDAcally located group 2 mGluRs. Similarly, Burke and Hablitz EPSC area (1994) recently showed that 1S,3R-ACPD decreased glutamate release in rat neocortex and that L-AP3 did not block
The present results suggest that at least the group 2 and the group 3 mGluRs are expressed in the core NAcc (Table  this logical studies is particularly difficult. For example, the EC 50 of L-CCG-I for the cloned group 2 mGluR subtypes mGluR2 Received 7 May 1997; accepted in final form 18 August 1997. and mGluR3 ranges only from 0.3 to 1 mM, respectively (see review of Pin and Duvoisin 1995). However, with the REFERENCES recent availability of new probes, the pattern of expression of AKAZAWA, C., OHISHI, H., NAKAJIMA, Y., OKAMOTO, N., SHIGEMOTO, R., different mGluRs throughout the brain has been determined. NAKANISHI, S., AND MIZUNO, N. Expression of mRNAs of L-AP4 -sensitive metabotropic glutamate receptors (mGluR4, mGluR6, mGluR7) in Thus, for group 2 mGluRs, in situ hybridization showed that the rat retina. Neurosci. Lett. 171: 52-54, 1994. mGluR2 mRNA is heterogeneously distributed throughout AMBROSINI, A., BRESCIANI, L., FRACCHIA, S., BRUNELLO, N., AND RACAGNI, different brain regions, with high levels of expression in G. Metabotropic glutamate receptors negatively coupled to adenylate dentate gyrus, cerebellum, and olfactory bulb and moderate cyclase inhibit N-methyl-D-aspartate receptor activity and prevent neurotoxicity in mesencephalic neurons in vitro. Mol. Pharmacol. 47: 1057- to low levels in striatum and NAcc 1064 . Petralia et al. 1996 Testa et al. 1994b ). In contrast, there ANIKSZTEJN, L., OTANI, S., AND BEN-ARI, Y. Quisqualate metabotropic are high levels of mGluR3 mRNA labeling in striatum and receptors modulate NMDA currents and facilitate induction of long-term NAcc (Tanabe et al. 1993; Testa et al. 1994b The determination of the group 3 mGluR (i.e., mGluR4, sensitized rats. Brain Res. 729: 277-280, 1996. 6, 7, or 8) responsible for the postsynaptic L-AP4 effect is BASKYS, A. AND MALENKA, R. C. Agonists at metabotropic glutamate receptors presynaptically inhibit EPSCs in neonatal rat hippocampus. J. also difficult when based on pharmacology alone. Thus the
